{
  "docId": "019de074-2763-7087-8fbd-df19b6e58266",
  "docSlug": "1ca51573de190fbfcf19415b61000ddd",
  "documentTitle": "AstraZeneca | Investor Conference Presentation Deck | 18 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 18,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a list-based layout to categorize clinical milestones.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-2763-7087-8fbd-df19b6e58266/11",
  "deckHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266",
  "deckJsonHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266.json",
  "deckAnchorHref": "/decks/019de074-2763-7087-8fbd-df19b6e58266#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.9,
        "w": 0.25,
        "x": 0.02,
        "y": 0.05
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "589f1c00-598a-40e1-9036-047bbc19844f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.28,
        "y": 0.42
      },
      "kind": "list",
      "text": "Regulatory approvals in major markets, including:",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7c7cfc5b-f715-427d-bbae-1ff8e511bb11",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.28,
        "y": 0.22
      },
      "kind": "list",
      "text": "Positive Phase III data readouts, selected",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7282669-a0c3-47f9-9717-1cc443ed8b2d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.96,
        "x": 0.02,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "HER2-low = human epidermal growth factor receptor 2-low; NMOSD = neuromyelitis optica spectrum disorder; HFpEF = heart failure with preserved ejection fraction; ATTRv-PN = hereditary transthyretin-mediated amyloid polyneuropathy; PNH = paroxysmal nocturnal haemoglobinuria; EVH = extravascular haemolysis; gMG = generalised myasthenia gravis; HER2-positive = human epidermal growth factor receptor 2-positive; EGFRm = epidermal growth factor receptor mutated; RSV = respiratory syncytial virus; HRD-positive = homologous recombination deficiency-positive; NF1 = neurofibromatosis, type 1; PN = plexiform neurofibromas; aHUS = atypical haemolytic uraemic syndrome; CRPC = castrate-resistant cancer; chronic lymphocytic leukaemia; CLL = chronic lymphocytic leukaemia. Collaboration partners: Merck (Lynparza, Koselugo), Daiichi Sankyo (Enhertu), Sanofi (Beyfortus), Amgen (Tezspire).",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "447c358b-4ef1-44b8-a7a6-0c0121d1e924",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.28,
        "y": 0.13
      },
      "kind": "title",
      "text": "Exceptional delivery of best-in-industry pipeline",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dca6eb87-b654-4365-a641-da84d6f8038b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.28,
        "y": 0.05
      },
      "kind": "title",
      "text": "2022: An incredible year of clinical success",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5afad5fa-cdb0-4b60-a51a-e29937aca18f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "1928505f-be27-4654-b57a-8fb832759f37",
      "evidence": "list/bullet: Regulatory approvals in major markets, including:",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 3,
      "beatId": "577d5e60-d812-43a3-83a5-243b94cfd455",
      "arcName": "The Golden Circle",
      "arcSlug": "golden-circle",
      "beatName": "Executive Summary",
      "beatSlug": null,
      "evidence": "Summarizing the company's position and strategy for growth.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "88983257-4d74-4000-ae54-8166a2051abc",
      "evidence": "The loop is visible in how the presentation starts with the company's mission and weaves through its growth strategy.",
      "position": 0,
      "objective": "To explain why AstraZeneca is positioned for growth and how it plans to achieve it",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.8,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}